Eyenovia Inc (EYEN) concluded trading on Wednesday at a closing price of $15.82, with 4.62 million shares of worth about $73.06 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 109.93% during that period and on July 02, 2025 the price saw a gain of about 49.81%. Currently the company’s common shares owned by public are about 2.83M shares, out of which, 2.82M shares are available for trading.
Stock saw a price change of 65.65% in past 5 days and over the past one month there was a price change of 847.31%. Year-to-date (YTD), EYEN shares are showing a performance of -66.71% which increased to 35.45% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.85 but also hit the highest price of $124.80 during that period. The average intraday trading volume for Eyenovia Inc shares is 4.37 million. The stock is currently trading 152.03% above its 20-day simple moving average (SMA20), while that difference is up 378.61% for SMA50 and it goes to 32.48% higher than SMA200.
Eyenovia Inc (NASDAQ: EYEN) currently have 2.83M outstanding shares and institutions hold larger chunk of about 23.71% of that.
The stock has a current market capitalization of $45.61M and its 3Y-monthly beta is at 2.46. It has posted earnings per share of -$44.81 in the same period. It has Quick Ratio of 0.34. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EYEN, volatility over the week remained 41.15% while standing at 48.20% over the month.
Analysts are in expectations that Eyenovia Inc (EYEN) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on November 18, 2024 offering a Neutral rating for the stock and assigned a target price range of between $12 and $2 to it. Coverage by Northland Capital stated Eyenovia Inc (EYEN) stock as an Outperform in their note to investors on March 01, 2021, suggesting a price target of $10 for the stock.
